{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T22:33:20Z","timestamp":1789943600596,"version":"4.0.1"},"reference-count":76,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T00:00:00Z","timestamp":1493078400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T00:00:00Z","timestamp":1493078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Grants-in-Aid for Scientific Research","award":["16390348"],"award-info":[{"award-number":["16390348"]}]},{"name":"Grants-in-Aid for Scientific Research","award":["20390334"],"award-info":[{"award-number":["20390334"]}]},{"name":"Grants-in-Aid for Scientific Research","award":["17590901"],"award-info":[{"award-number":["17590901"]}]},{"name":"Grants-in-Aid for Scientific Research","award":["20591033"],"award-info":[{"award-number":["20591033"]}]},{"name":"Grants-in-Aid for Scientific Research","award":["23591287"],"award-info":[{"award-number":["23591287"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Synapse"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1002\/syn.21979","type":"journal-article","created":{"date-parts":[[2017,4,13]],"date-time":"2017-04-13T18:29:52Z","timestamp":1492108192000},"page":"e21979","source":"Crossref","is-referenced-by-count":18,"title":["Adenosine A<sub>1<\/sub>receptors measured with<sup>11<\/sup>C-MPDX PET in early Parkinson's disease"],"prefix":"10.1002","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8227-0930","authenticated-orcid":false,"given":"Masahiro","family":"Mishina","sequence":"first","affiliation":[{"name":"Department of Neuro-pathophysiological Imaging, Graduate School of Medicine; Nippon Medical School; 1-396 Kosugi, Nakahara Kawasaki Kanagawa 211-8533 Japan"},{"name":"Research Team for Neuroimaging; Tokyo Metropolitan Institute of Gerontology; 35-2 Sakae-cho Itabashi Tokyo 173-0015 Japan"},{"name":"Department of Neurology; Nippon Medical School, Musashi Kosugi Hospital; 1-396 Kosugi, Nakahara Kawasaki Kanagawa 211-8533 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ishii","sequence":"additional","affiliation":[{"name":"Research Team for Neuroimaging; Tokyo Metropolitan Institute of Gerontology; 35-2 Sakae-cho Itabashi Tokyo 173-0015 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Research Team for Neuroimaging; Tokyo Metropolitan Institute of Gerontology; 35-2 Sakae-cho Itabashi Tokyo 173-0015 Japan"},{"name":"Department of Computational Systems Biology, Faculty of Biology-Oriented Science and Technology; Kinki University; 930 Nishimitani Kinokawa Wakayama 649-6493 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Research Team for Neuroimaging; Tokyo Metropolitan Institute of Gerontology; 35-2 Sakae-cho Itabashi Tokyo 173-0015 Japan"},{"name":"Department of Neurology; Katsushika Medical Center, The Jikei University School of Medicine; 6-41-2 Aoto Katsushika Tokyo 125-850 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Kitamura","sequence":"additional","affiliation":[{"name":"Department of Neurology; Nippon Medical School, Musashi Kosugi Hospital; 1-396 Kosugi, Nakahara Kawasaki Kanagawa 211-8533 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ishibashi","sequence":"additional","affiliation":[{"name":"Research Team for Neuroimaging; Tokyo Metropolitan Institute of Gerontology; 35-2 Sakae-cho Itabashi Tokyo 173-0015 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneyuki","family":"Sakata","sequence":"additional","affiliation":[{"name":"Research Team for Neuroimaging; Tokyo Metropolitan Institute of Gerontology; 35-2 Sakae-cho Itabashi Tokyo 173-0015 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Oda","sequence":"additional","affiliation":[{"name":"Research Team for Neuroimaging; Tokyo Metropolitan Institute of Gerontology; 35-2 Sakae-cho Itabashi Tokyo 173-0015 Japan"},{"name":"Department of Radiological Technology, Faculty of Health Sciences; Hokkaido University of Science; 7-Jo 15-4-1 Maeda, Teine Sapporo Hokkaido 006-8585 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery; Nippon Medical School, Chiba Hokusoh Hospital; 1715 Kamagari Inzai Chiba 270-1694 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Neurological Science, Graduate School of Medicine; Nippon Medical School; 1-1-5 Sendagi Bunkyo Tokyo 113-8602 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiichi","family":"Ishiwata","sequence":"additional","affiliation":[{"name":"Research Team for Neuroimaging; Tokyo Metropolitan Institute of Gerontology; 35-2 Sakae-cho Itabashi Tokyo 173-0015 Japan"},{"name":"Institute of Cyclotron and Drug Discovery Research, Southern TOHOKU Research Institute for Neuroscience; 7-1 15 Yatsuyamada Koriyama Fukushima 963-8563 Japan"},{"name":"Department of Biofunctional Imaging; Fukushima Medical University; 1 Hikariga-oka Fukushima Fukushima 960-1295 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,4,25]]},"reference":[{"issue":"1","key":"10.1002\/syn.21979-BIB0001|syn21979-cit-0002","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0167-4889(02)00330-0","article-title":"Adenosine A1 receptor agonist treatment up-regulates rat brain metabotropic glutamate receptors","volume":"1593","author":"Albasanz","year":"2002","journal-title":"Biochim Biochimica Et Biophysica Acta"},{"issue":"7","key":"10.1002\/syn.21979-BIB0002|syn21979-cit-0003","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0166-2236(90)90107-L","article-title":"Functional architecture of basal ganglia circuits: neural substrates of parallel processing","volume":"13","author":"Alexander","year":"1990","journal-title":"Trends in Neurosciences"},{"issue":"5","key":"10.1002\/syn.21979-BIB0003|syn21979-cit-0004","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1212\/01.WNL.0000046523.05125.87","article-title":"Caffeine, postmenopausal estrogen, and risk of Parkinson's disease","volume":"60","author":"Ascherio","year":"2003","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/syn.21979-BIB0004|syn21979-cit-0005","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ana.1052","article-title":"Prospective study of caffeine consumption and risk of Parkinson's disease in men and women","volume":"50","author":"Ascherio","year":"2001","journal-title":"Annals of Neurology"},{"issue":"1","key":"10.1002\/syn.21979-BIB0005|syn21979-cit-0006","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.20296","article-title":"Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia","volume":"57","author":"Aubert","year":"2005","journal-title":"Annals of Neurology"},{"issue":"9","key":"10.1002\/syn.21979-BIB0006|syn21979-cit-0007","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1212\/WNL.55.9.1350","article-title":"Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study","volume":"55","author":"Benedetti","year":"2000","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/syn.21979-BIB0007|syn21979-cit-0008","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/ajcn\/86.1.240","article-title":"Genetic polymorphism of the adenosine A2A receptor is associated with habitual caffeine consumption","volume":"86","author":"Cornelis","year":"2007","journal-title":"American Journal of Clinical Nutrition"},{"issue":"11","key":"10.1002\/syn.21979-BIB0008|syn21979-cit-0009","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/00001756-199507310-00029","article-title":"Modification of A1 and A2a adenosine receptor binding in aged striatum, hippocampus and cortex of the rat","volume":"6","author":"Cunha","year":"1995","journal-title":"Neuroreport"},{"issue":"10","key":"10.1002\/syn.21979-BIB0009|syn21979-cit-0010","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1046\/j.1432-1327.2001.02183.x","article-title":"Age-dependent decrease in adenosine A1 receptor binding sites in the rat brain. Effect of cis unsaturated free fatty acids","volume":"268","author":"Cunha","year":"2001","journal-title":"European Journal of Biochemistry"},{"issue":"3","key":"10.1002\/syn.21979-BIB0010|syn21979-cit-0011","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neulet.2007.10.037","article-title":"A1 and A2A receptor activation by endogenous adenosine is required for VIP enhancement of K+-evoked [3H]-GABA release from rat hippocampal nerve terminals","volume":"430","author":"Cunha-Reis","year":"2008","journal-title":"Neuroscience Letters"},{"issue":"6","key":"10.1002\/syn.21979-BIB0011|syn21979-cit-0012","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"issue":"2","key":"10.1002\/syn.21979-BIB0012|syn21979-cit-0013","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nn1632","article-title":"Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models","volume":"9","author":"Day","year":"2006","journal-title":"Nature Neuroscience"},{"issue":"1","key":"10.1002\/syn.21979-BIB0013|syn21979-cit-0014","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/1531-8257(199901)14:1<28::AID-MDS1007>3.0.CO;2-O","article-title":"Nutritional and occupational factors influencing the risk of Parkinson's disease: a case-control study in southeastern Sweden","volume":"14","author":"Fall","year":"1999","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"1","key":"10.1002\/syn.21979-BIB0014|syn21979-cit-0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00001756-199412300-00020","article-title":"Postsynaptic antagonistic interaction between adenosine A1 and dopamine D1 receptors","volume":"6","author":"Ferre","year":"1994","journal-title":"Neuroreport"},{"issue":"16","key":"10.1002\/syn.21979-BIB0015|syn21979-cit-0016","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1073\/pnas.88.16.7238","article-title":"Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes","volume":"88","author":"Ferre","year":"1991","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1002\/syn.21979-BIB0016|syn21979-cit-0017","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.neuroscience.2014.09.060","article-title":"Caffeine potentiates the release of GABA mediated by NMDA receptor activation: Involvement of A1 adenosine receptors","volume":"281","author":"Ferreira","year":"2014","journal-title":"Neuroscience"},{"issue":"1","key":"10.1002\/syn.21979-BIB0017|syn21979-cit-0018","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0031-6997(24)01396-6","article-title":"Actions of caffeine in the brain with special reference to factors that contribute to its widespread use","volume":"51","author":"Fredholm","year":"1999","journal-title":"Pharmacological Reviews"},{"issue":"11 Suppl 6","key":"10.1002\/syn.21979-BIB0018|syn21979-cit-0019","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1212\/01.WNL.0000095204.89871.FF","article-title":"Adenosine-dopamine interactions: Development of a concept and some comments on therapeutic possibilities","volume":"61","author":"Fredholm","year":"2003","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/syn.21979-BIB0019|syn21979-cit-0020","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF03165298","article-title":"Performance evaluation of a large axial field-of-view PET scanner: SET-2400W","volume":"11","author":"Fujiwara","year":"1997","journal-title":"Annals of Nuclear Medicine"},{"issue":"1","key":"10.1002\/syn.21979-BIB0020|syn21979-cit-0021","first-page":"32","article-title":"Adenosine A1 receptor mapping of the human brain by PET with 8-dicyclopropylmethyl-1-11C-methyl-3-propylxanthine","volume":"46","author":"Fukumitsu","year":"2005","journal-title":"Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine"},{"issue":"1","key":"10.1002\/syn.21979-BIB0021|syn21979-cit-0022","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0197-0186(95)00137-9","article-title":"Both adenosine A1- and A2-receptors are required to stimulate microglial proliferation","volume":"29","author":"Gebicke-Haerter","year":"1996","journal-title":"Neurochemical International"},{"issue":"1","key":"10.1002\/syn.21979-BIB0022|syn21979-cit-0023","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archneur.56.1.33","article-title":"Diagnostic criteria for Parkinson disease","volume":"56","author":"Gelb","year":"1999","journal-title":"Archives of Neurology"},{"issue":"1","key":"10.1002\/syn.21979-BIB0023|syn21979-cit-0024","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1172\/JCI112280","article-title":"Chronic caffeine ingestion sensitizes the A1 adenosine receptor-adenylate cyclase system in rat cerebral cortex","volume":"77","author":"Green","year":"1986","journal-title":"Journal of Clinical Investigation"},{"issue":"8","key":"10.1002\/syn.21979-BIB0024|syn21979-cit-0025","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S1474-4422(14)70148-6","article-title":"Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial","volume":"13","author":"Hauser","year":"2014","journal-title":"Lancet the Neurology"},{"issue":"3","key":"10.1002\/syn.21979-BIB0025|syn21979-cit-0026","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/1096-9861(20010312)431:3<331::AID-CNE1074>3.0.CO;2-W","article-title":"Ultrastructural localization of adenosine A2A receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatum","volume":"431","author":"Hettinger","year":"2001","journal-title":"Journal of Comparative Neurology"},{"issue":"1","key":"10.1002\/syn.21979-BIB0026|syn21979-cit-0027","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00259-009-1202-1","article-title":"Validation of cardiac 123I-MIBG scintigraphy in patients with Parkinson's disease who were diagnosed with dopamine PET","volume":"37","author":"Ishibashi","year":"2010","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"3","key":"10.1002\/syn.21979-BIB0027|syn21979-cit-0028","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archneur.62.3.351","article-title":"Progression of Parkinson disease: Are we making progress in charting the course?","volume":"62","author":"Jankovic","year":"2005","journal-title":"Archives of Neurology"},{"issue":"6","key":"10.1002\/syn.21979-BIB0028|syn21979-cit-0029","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.parkreldis.2008.12.006","article-title":"Adenosine, adenosine A2A antagonists, and Parkinson's disease","volume":"15","author":"Jenner","year":"2009","journal-title":"Parkinsonism & Related Disorders"},{"issue":"4","key":"10.1002\/syn.21979-BIB0029|syn21979-cit-0030","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/mds.870070407","article-title":"Premorbid smoking, alcohol consumption, and coffee drinking habits in Parkinson's disease: A case-control study","volume":"7","author":"Jimenez-Jimenez","year":"1992","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"1","key":"10.1002\/syn.21979-BIB0030|syn21979-cit-0031","first-page":"65","article-title":"Upregulation of putaminal dopamine D2 receptors in early Parkinson's disease: a comparative PET study with [11C] raclopride and [11C]N-methylspiperone","volume":"41","author":"Kaasinen","year":"2000","journal-title":"Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine"},{"issue":"2","key":"10.1002\/syn.21979-BIB0031|syn21979-cit-0032","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/mds.25273","article-title":"Novel nondopaminergic targets for motor features of Parkinson's disease: review of recent trials","volume":"28","author":"Kalia","year":"2013","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"3","key":"10.1002\/syn.21979-BIB0032|syn21979-cit-0033","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF02990030","article-title":"Age-related changes of the [11C]CFT binding to the striatal dopamine transporters in the Fischer 344 rats: A PET study","volume":"17","author":"Kawamura","year":"2003","journal-title":"Annals of Nuclear Medicine"},{"issue":"4","key":"10.1002\/syn.21979-BIB0033|syn21979-cit-0034","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00213-008-1319-0","article-title":"The effects of systemic, intrastriatal, and intrapallidal injections of caffeine and systemic injections of A2A and A1 antagonists on forepaw stepping in the unilateral 6-OHDA-lesioned rat","volume":"201","author":"Kelsey","year":"2009","journal-title":"Psychopharmacology"},{"issue":"8","key":"10.1002\/syn.21979-BIB0034|syn21979-cit-0035","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.nucmedbio.2004.06.005","article-title":"Quantitative analysis of adenosine A1 receptors in human brain using positron emission tomography and [1-methyl-11C]8-dicyclopropylmethyl-1-methyl-3-propylxanthine","volume":"31","author":"Kimura","year":"2004","journal-title":"Nuclear Medicine Biology"},{"issue":"1 Suppl 1","key":"10.1002\/syn.21979-BIB0035|syn21979-cit-0036","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1212\/WNL.49.1_Suppl_1.S10","article-title":"Issues in the early diagnosis of Parkinson's disease","volume":"49","author":"Koller","year":"1997","journal-title":"Neurology"},{"issue":"7306","key":"10.1002\/syn.21979-BIB0036|syn21979-cit-0037","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nature09159","article-title":"Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry","volume":"466","author":"Kravitz","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1002\/syn.21979-BIB0037|syn21979-cit-0038","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00002826-200201000-00005","article-title":"A double-blind crossover, placebo-controlled study of the adenosine A2A antagonist theophylline in Parkinson's disease","volume":"25","author":"Kulisevsky","year":"2002","journal-title":"Clinical Neuropharmacology"},{"issue":"10","key":"10.1002\/syn.21979-BIB0038|syn21979-cit-0039","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1001\/jama.296.10.1255","article-title":"Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: The Ohsaki study","volume":"296","author":"Kuriyama","year":"2006","journal-title":"JAMA"},{"key":"10.1002\/syn.21979-BIB0039|syn21979-cit-0040","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/(SICI)1099-1344(199912)42:12<1183::AID-JLCR274>3.0.CO;2-Z","article-title":"Precursor synthesis and radiolabelling of the dopamine D2 receptor ligand [11C]raclopride from [11C]methyl triflate","volume":"42","author":"Langer","year":"1999","journal-title":"Journal of Labelled Compounds & Radiopharmaceuticals"},{"issue":"9680","key":"10.1002\/syn.21979-BIB0040|syn21979-cit-0041","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","article-title":"Parkinson's disease","volume":"373","author":"Lees","year":"2009","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/syn.21979-BIB0041|syn21979-cit-0042","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.neuroscience.2007.11.020","article-title":"Chronic but not acute treatment with caffeine attenuates traumatic brain injury in the mouse cortical impact model","volume":"151","author":"Li","year":"2008","journal-title":"Neuroscience"},{"issue":"8","key":"10.1002\/syn.21979-BIB0042|syn21979-cit-0043","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0969-8051(03)00114-8","article-title":"A review of graphical methods for tracer studies and strategies to reduce bias","volume":"30","author":"Logan","year":"2003","journal-title":"Nuclear Medicine & Biology"},{"issue":"4","key":"10.1002\/syn.21979-BIB0043|syn21979-cit-0044","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1046\/j.1471-4159.1999.731733.x","article-title":"Increase in the number, G protein coupling, and efficiency of facilitatory adenosine A2A receptors in the limbic cortex, but not striatum, of aged rats","volume":"73","author":"Lopes","year":"1999","journal-title":"Journal of Neurochemistry"},{"issue":"12","key":"10.1002\/syn.21979-BIB0044|syn21979-cit-0045","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/syn.21979-BIB0045|syn21979-cit-0046","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0006-8993(88)90124-2","article-title":"Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease","volume":"455","author":"McNeill","year":"1988","journal-title":"Brain Research"},{"issue":"5","key":"10.1002\/syn.21979-BIB0046|syn21979-cit-0047","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/jnr.20314","article-title":"Ageing-related decline in adenosine A1 receptor binding in the rat brain: an autoradiographic study","volume":"78","author":"Meerlo","year":"2004","journal-title":"Journal of Neuroscience Research"},{"issue":"2","key":"10.1002\/syn.21979-BIB0047|syn21979-cit-0048","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/197140091102400211","article-title":"Striatal distribution of dopamine transporters and Ddopamine D2 receptors at different stages of Parkinson's disease-A CFT and RAC PET study","volume":"24","author":"Mishina","year":"2011a","journal-title":"Neuroradiology Journal"},{"key":"10.1002\/syn.21979-BIB0048|syn21979-cit-0049","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/B978-0-12-801022-8.00002-7","article-title":"Adenosine receptor PET imaging in human brain","volume":"119","author":"Mishina","year":"2014","journal-title":"International Review of Neurobiology"},{"issue":"2","key":"10.1002\/syn.21979-BIB0049|syn21979-cit-0050","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1600-0404.2005.00432.x","article-title":"Function of sigma1 receptors in Parkinson's disease","volume":"112","author":"Mishina","year":"2005","journal-title":"Acta Neurologica Scandinavica"},{"issue":"suppl 1","key":"10.1002\/syn.21979-BIB0050|syn21979-cit-0051","first-page":"S202","article-title":"Aging effect on adenosine A2A receptors in putamen -A 11C-TMSX PET study","volume":"24","author":"Mishina","year":"2009","journal-title":"Movement Disorders"},{"issue":"2","key":"10.1002\/syn.21979-BIB0051|syn21979-cit-0052","doi-asserted-by":"crossref","first-page":"e17338","DOI":"10.1371\/journal.pone.0017338","article-title":"Adenosine A2A receptors measured with [11C]TMSX PET in the striata of Parkinson's disease patients","volume":"6","author":"Mishina","year":"2011b","journal-title":"PLoS One"},{"issue":"3","key":"10.1002\/syn.21979-BIB0052|syn21979-cit-0053","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF02987859","article-title":"Intrasubject correlation between static scan and distribution volume images for [11C]flumazenil PET","volume":"14","author":"Mishina","year":"2000","journal-title":"Annals of Nuclear Medicine"},{"issue":"10","key":"10.1002\/syn.21979-BIB0053|syn21979-cit-0054","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/mds.23107","article-title":"Clinical efficacy of istradefylline (KW-6002) in Parkinson's disease: A randomized, controlled study","volume":"25","author":"Mizuno","year":"2010","journal-title":"Movement Disorders"},{"issue":"11 Suppl 6","key":"10.1002\/syn.21979-BIB0054|syn21979-cit-0055","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1212\/01.WNL.0000095211.71092.A0","article-title":"Modulation of GABAergic transmission in the striatopallidal system by adenosine A2A receptors: A potential mechanism for the antiparkinsonian effects of A2A antagonists","volume":"61","author":"Mori","year":"2003","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/syn.21979-BIB0055|syn21979-cit-0056","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.bbamem.2010.12.017","article-title":"Recent developments in adenosine receptor ligands and their potential as novel drugs","volume":"1808","author":"M\u00fcller","year":"2011","journal-title":"Biochim Biochimica Et Biophysica Acta"},{"issue":"2","key":"10.1002\/syn.21979-BIB0056|syn21979-cit-0057","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0168-0102(02)00027-5","article-title":"Functional significance of the cortico-subthalamo-pallidal \u2018hyperdirect\u2019 pathway","volume":"43","author":"Nambu","year":"2002","journal-title":"Neuroscience Research"},{"issue":"2","key":"10.1002\/syn.21979-BIB0057|syn21979-cit-0058","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0165-0173(92)90012-B","article-title":"Caffeine and the central nervous system: Mechanisms of action, biochemical, metabolic and psychostimulant effects","volume":"17","author":"Nehlig","year":"1992","journal-title":"Brain Research Reviews"},{"issue":"1","key":"10.1002\/syn.21979-BIB0058|syn21979-cit-0059","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0969-8051(96)00161-8","article-title":"Evaluation of carbon-11 labeled KF15372 and its ethyl and methyl derivatives as a potential CNS adenosine A1 receptor ligand","volume":"24","author":"Noguchi","year":"1997","journal-title":"Nuclear Medicine & Biology"},{"issue":"5","key":"10.1002\/syn.21979-BIB0059|syn21979-cit-0060","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/1531-8249(199911)46:5<723::AID-ANA7>3.0.CO;2-R","article-title":"Presynaptic and postsynaptic dopaminergic binding densities in the nigrostriatal and mesocortical systems in early Parkinson's disease: A double-tracer positron emission tomography study","volume":"46","author":"Ouchi","year":"1999","journal-title":"Annals of Neurology"},{"issue":"8","key":"10.1002\/syn.21979-BIB0060|syn21979-cit-0061","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.2967\/jnumed.111.088005","article-title":"Small-animal PET study of adenosine A1 receptors in rat brain: Blocking receptors and raising extracellular adenosine","volume":"52","author":"Paul","year":"2011","journal-title":"Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine"},{"issue":"7","key":"10.1002\/syn.21979-BIB0061|syn21979-cit-0062","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/syn.20326","article-title":"Subcellular distributions of adenosine A1 and A2A receptors in the rat dorsomedial nucleus of the solitary tract at the level of the area postrema","volume":"60","author":"Pickel","year":"2006","journal-title":"Synapse"},{"issue":"Pt 8","key":"10.1002\/syn.21979-BIB0062|syn21979-cit-0063","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/brain\/122.8.1449","article-title":"Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: Rostrocaudal distribution","volume":"122","author":"Piggott","year":"1999","journal-title":"Brain"},{"issue":"2","key":"10.1002\/syn.21979-BIB0063|syn21979-cit-0064","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1152\/jn.00896.2002","article-title":"Enhanced adenosine A2A receptor facilitation of synaptic transmission in the hippocampus of aged rats","volume":"90","author":"Rebola","year":"2003","journal-title":"Journal of Neurophysiology"},{"issue":"4","key":"10.1002\/syn.21979-BIB0064|syn21979-cit-0065","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/gps.606","article-title":"Ageing and the nigrostriatal dopaminergic system. International Journal of","volume":"17","author":"Reeves","year":"2002","journal-title":"Geriatric Psychiatry"},{"issue":"Suppl 1","key":"10.1002\/syn.21979-BIB0065|syn21979-cit-0066","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.3233\/JAD-2010-1379","article-title":"Caffeine and adenosine","volume":"20","author":"Ribeiro","year":"2010","journal-title":"Journal of Alzheimer's Disease"},{"issue":"4","key":"10.1002\/syn.21979-BIB0066|syn21979-cit-0067","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1001\/archneur.59.4.580","article-title":"Dopaminergic function and dopamine transporter binding assessed with positron emission tomography in Parkinson disease","volume":"59","author":"Ribeiro","year":"2002","journal-title":"Archives of Neurology"},{"issue":"11 Suppl 6","key":"10.1002\/syn.21979-BIB0067|syn21979-cit-0068","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1212\/01.WNL.0000095205.33940.99","article-title":"Anatomy of adenosine A2A receptors in brain: Morphological substrates for integration of striatal function","volume":"61","author":"Rosin","year":"2003","journal-title":"Neurology"},{"issue":"20","key":"10.1002\/syn.21979-BIB0068|syn21979-cit-0069","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1001\/jama.283.20.2674","article-title":"Association of coffee and caffeine intake with the risk of Parkinson disease","volume":"283","author":"Ross","year":"2000","journal-title":"JAMA"},{"issue":"8","key":"10.1002\/syn.21979-BIB0069|syn21979-cit-0070","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1212\/WNL.58.8.1154","article-title":"Caffeinated clues and the promise of adenosine A2A antagonists in PD","volume":"58","author":"Schwarzschild","year":"2002","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/syn.21979-BIB0070|syn21979-cit-0071","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/CRD.0b013e31819f1a98","article-title":"Adenosine1 receptor antagonism: A new therapeutic approach for the treatment of decompensated heart failure","volume":"17","author":"Shah","year":"2009","journal-title":"Cardiology in Review"},{"issue":"5","key":"10.1002\/syn.21979-BIB0071|syn21979-cit-0072","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/jnnp.56.5.467","article-title":"Dopamine D1 receptors in Parkinson's disease and striatonigral degeneration: A positron emission tomography study","volume":"56","author":"Shinotoh","year":"1993","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"3","key":"10.1002\/syn.21979-BIB0072|syn21979-cit-0073","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/ajcp\/73.3.390","article-title":"Serum caffeine half-lives. Healthy subjects vs. patients having alcoholic hepatic disease","volume":"73","author":"Statland","year":"1980","journal-title":"American Journal of Clinical Pathology"},{"issue":"3","key":"10.1002\/syn.21979-BIB0073|syn21979-cit-0074","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1212\/WNL.49.3.717","article-title":"In vivo studies on striatal dopamine D1 and D2 site binding in l-dopa-treated Parkinson's disease patients with and without dyskinesias","volume":"49","author":"Turjanski","year":"1997","journal-title":"Neurology"},{"key":"10.1002\/syn.21979-BIB0074|syn21979-cit-0075","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.brainres.2010.08.099","article-title":"Deletion of adenosine A1 or A2A receptors reduces L-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's disease","volume":"1367","author":"Xiao","year":"2011","journal-title":"Brain Research"},{"issue":"1","key":"10.1002\/syn.21979-BIB0075|syn21979-cit-0076","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuroscience.2006.04.047","article-title":"Role of adenosine A1 receptors in the modulation of dopamine D1 and adenosine A2A receptor signaling in the neostriatum","volume":"141","author":"Yabuuchi","year":"2006","journal-title":"Neuroscience"},{"issue":"3","key":"10.1002\/syn.21979-BIB0076|syn21979-cit-0077","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1212\/01.WNL.0000150591.33787.A4","article-title":"Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease","volume":"64","author":"Zaja-Milatovic","year":"2005","journal-title":"Neurology"}],"container-title":["Synapse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fsyn.21979","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/syn.21979","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T22:22:12Z","timestamp":1750198932000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/syn.21979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,25]]},"references-count":76,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"URL":"https:\/\/doi.org\/10.1002\/syn.21979","archive":["Portico"],"relation":{},"ISSN":["0887-4476"],"issn-type":[{"value":"0887-4476","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4,25]]}}}